Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Executive Summary

FLORIDA PHARMACISTS MAY PRESCRIBE ANTIHISTAMINES, DECONGESTANTS, fluoride products, and lindane products under a bill passed by the Florida state legislature May 14 and signed into law May 24 by Gov. Bob Graham. The law redefines the term "prescription" to include a pharmacist's order for specified drugs and provides for creation of a cmte. to establish a formulary of medicinal drugs that a pharmacist may prescribe. The law goes into effect Oct. 1, 1985. Under the law, the cmte. in developing the formulary may include products falling within the following categories: (1) "any medicinal drug of single or multiple active ingredients in any strengths when such active ingredients have been approved individually or in combination for OTC sale" by FDA; (2) any medicinal drug recommended by an FDA advisory panel for transfer to OTC status pending approval by FDA; (3) "any medicinal drug containing any antihistamine or decongestant as a single active ingredient or in combination"; (4) "any medicinal drug containing fluoride in any strength"; and (5) "any medicinal drug containing lindane in any strength." The cmte. to set up the formulary will consist of two members of the Board of Medical Examiners, one member of the Board of Osteopathic Medical Examiners, three members of the Board of Pharmacy and one additional person with a background in health care or pharmacology chosen by the cmte. A provision of the law disallows any OTC proprietary drug from being included in the formulary. The law also states that "any drug product ordered by a pharmacist shall be selected and dispensed only by the pharmacist so ordering and said order shall not be refilled, nor shall another medicinal drug be ordered for the same condition unless such act is consistent with dispensing procedures established by the cmte."

You may also be interested in...

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance

FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials

Shire Hopes To Sow Future Deals With $50M Venture Fund

Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts